首页> 美国政府科技报告 >SLCO2B1 and SLCO1B3 as New Targets for Enhancing Androgen Deprivation Therapy for Prostate Cancer.

【24h】

SLCO2B1 and SLCO1B3 as New Targets for Enhancing Androgen Deprivation Therapy for Prostate Cancer.

机译：sLCO2B1和sLCO1B3作为增强雄激素剥夺治疗前列腺癌的新靶点。

获取原文

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Kantoff, P. W.;
展开▼
作者单位

展开▼
年度 2016
页码 1-89
总页数 89
原文格式 PDF
正文语种 eng
中图分类
关键词
Prostate cancer; Androgen deprivation therapy;

机译：前列腺癌;雄激素剥夺疗法;

相似文献

外文文献
中文文献
专利

1. SLCO2B1 and SLCO1B3 May Determine Time to Progression for Patients Receiving Androgen Deprivation Therapy for Prostate Cancer. [J] . Yang M, Xie W, Mostaghel E, Journal of Clinical Oncology . 2011,第18期

机译：SLCO2B1和SLCO1B3可能决定接受前列腺癌雄激素剥夺疗法的患者的进展时间。
2. Association of SLCO2B1 Genotypes With Time to Progression and Overall Survival in Patients Receiving Androgen-Deprivation Therapy for Prostate Cancer [J] . Wang Xiaodong, Harshman Lauren C., Xie Wanling, Journal of Clinical Oncology . 2016,第4期

机译：SLCO2B1基因型随时间与进展和总生存期接受前列腺癌的雄激素剥夺治疗
3. Phase II study of neoadjuvant androgen deprivation followed by external-beam radiotherapy with 9 months of androgen deprivation for intermediate- to high-risk localized prostate cancer. [J] . Heymann JJ, Benson MC, OToole KM, Journal of Clinical Oncology . 2007,第1期

机译：II期新辅助雄激素剥夺，然后进行9个月雄激素剥夺的外照射治疗，用于中至高危局限性前列腺癌。
4. Serum levels of sex hormones before and after androgen deprivation therapy in Japanese prostate cancer patients [C] . A. Komiya, K. Ichimatsu, A. Morii, International Congress of Andrology . 2009

机译：日本前列腺癌患者中雄激素剥夺治疗前后的性激素血清水平
5. Impact of androgen deprivation therapy on quality of life in men with stage IV prostate cancer. [D] . Withrow, Susanne. 2016

机译：雄激素剥夺治疗对IV期前列腺癌男性生活质量的影响。
6. SLCO2B1 and SLCO1B3 May Determine Time to Progression for Patients Receiving Androgen Deprivation Therapy for Prostate Cancer [O] . Ming Yang, Wanling Xie, Elahe Mostaghel, -1

机译：SLCO2B1和SLCO1B3可能决定接受前列腺癌雄激素剥夺疗法的患者的进展时间
7. SLCO2B1 and SLCO1B3 May Determine Time to Progression for Patients Receiving Androgen Deprivation Therapy for Prostate Cancer [O] . Yang, Ming, Xie, Wanling, Mostaghel, Elahe, 2011

机译：SLCO2B1和SLCO1B3可能决定接受前列腺癌雄激素剥夺疗法的患者的进展时间

SLCO2B1 and SLCO1B3 as New Targets for Enhancing Androgen Deprivation Therapy for Prostate Cancer.

著录项

引文网络

相似文献

相关主题

期刊订阅